PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
32565935-0	2020	Ubiquitin-specific peptidase 17 promotes cisplatin resistance via PI3K/AKT activation in non-small cell lung cancer.	Cisplatin	41-50	AKT serine/threonine kinase 1	Homo sapiens	71-74	
32565935-10	2020	Overall, the results of the present study suggest that PI3K/AKT activation is the underlying mechanism of USP17-mediated cisplatin resistance in NSCLC.	Cisplatin	121-130	AKT serine/threonine kinase 1	Homo sapiens	60-63